HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB:PWRM) (https://www.power3medical.com) announced today that Dr. Marwan Sabbagh, Chief Medical-Scientific Officer of Sun Health and Dr. Ira L. Goldknopf, President and Chief Scientific Officer of Power3, have jointly submitted an abstract entitled “Development of a novel biomarker approach for detection of Alzheimer’s disease” for presentation by Dr. Sabbagh to the 61st annual meeting of the American Academy of Neurology to take place in Seattle on April 25 – May 1, 2009. Power3 Medical is a leading biomedical company specializing in the development and commercialization of protein based diagnostic blood tests for the early detection of breast cancer and neurodegenerative diseases.
